Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.45 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.36 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.36 |
| ▸ | ANPEP | P15144 | 5/20 | 0.35 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.35 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.32 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.32 |
| ▸ | LAP3 | P28838 | 3/20 | 0.31 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.31 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.31 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | LARS1 | Q9P2J5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10523425 | 1.00 | ALDH1A1 (0.50) | ALDH1A1SLC7A5SLC1A3SLC1A2ANPEP | |
| SCHEMBL15655614 | 0.90 | SLC7A5 (0.50) | ALDH1A1SLC7A5SLC1A3SLC1A2ANPEP | |
| SCHEMBL542258 | 0.90 | SLC7A5 (0.50) | ALDH1A1SLC7A5SLC1A3SLC1A2ANPEP | |
| SCHEMBL6136333 | 0.86 | SLC7A5 (0.50) | ALDH1A1SLC7A5SLC1A3SLC1A2ANPEP | |
| SCHEMBL1681185 | 0.86 | LMNA (0.50) | ALDH1A1MAPTLMNA | |
| SCHEMBL17204053 | 0.86 | LMNA (0.50) | ALDH1A1MAPTLMNA | |
| SCHEMBL2910121 | 0.86 | LMNA (0.50) | ALDH1A1MAPTLMNA | |
| SCHEMBL15649603 | 0.86 | LMNA (0.50) | ALDH1A1MAPTLMNA | |
| SCHEMBL898814 | 0.86 | LMNA (0.50) | ALDH1A1MAPTLMNA | |
| SCHEMBL9666285 | 0.86 | LMNA (0.50) | ALDH1A1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7714154-B2 | Preparation of amino acid-fatty acid anhydrides | NORTHERN INNOVATIONS AND FORMULATIONS CORP. (CA) | 2010-05-11 | — | — | US | disclosed |
| US-7511162-B2 | Preparation of amino acid-fatty acid anhydrides | MULTI FORMULATIONS LTD. (CA) | 2009-03-31 | — | — | US | disclosed |
| US-20080281113-A1 | Preparation of amino acid-fatty acid anhydrides | MULTI FORMULATIONS LTD (CA) | 2008-11-13 | — | — | US | disclosed |
| US-20080200725-A1 | Enhanced bioavailability; reacting fatty acid and amino acid using thionyl halide | 2462096 ONTARIO LIMITED (CA) | 2008-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080281113-A1 | Preparation of amino acid-fatty acid anhydrides | FABP2, FABP4, FABP1 | ALDH1A1 963/4885SLC7A5 53/4885SLC1A3 76/4885 |
| US-20080200725-A1 | Enhanced bioavailability; reacting fatty acid and amino acid using thionyl halide | FABP2, FABP1, FABP4 | ALDH1A1 991/4885SLC7A5 23/4885SLC1A3 66/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.